{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:43:54Z","timestamp":1790700234525,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["HONG14A0"],"award-info":[{"award-number":["HONG14A0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jcf.2018.01.008","type":"journal-article","created":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T00:21:50Z","timestamp":1518394910000},"page":"624-630","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Risk factors for persistent Aspergillus respiratory isolation in cystic fibrosis"],"prefix":"10.1016","volume":"17","author":[{"given":"Gina","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Psoter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian A.","family":"Merlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Hadjiliadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Kawut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Lechtzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.jcf.2018.01.008_bb0005","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1001\/jama.298.15.1787","article-title":"Adult cystic fibrosis","volume":"298","author":"Boyle","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jcf.2018.01.008_bb0010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/MRM.0b013e3282e1c70a","article-title":"Fungal infections in patients with cystic fibrosis","volume":"18","author":"Nagano","year":"2007","journal-title":"Rev Med Microbiol"},{"key":"10.1016\/j.jcf.2018.01.008_bb0015","series-title":"2012 annual data report","author":"Registry CFFP","year":"2013"},{"issue":"2","key":"10.1016\/j.jcf.2018.01.008_bb0020","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jcf.2009.11.010","article-title":"Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis","volume":"9","author":"Sudfeld","year":"2010","journal-title":"J Cyst Fibros"},{"issue":"8","key":"10.1016\/j.jcf.2018.01.008_bb0025","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/mmy\/myw035","article-title":"Fungal epidemiology and diversity in cystic fibrosis patients over a 5-year period in a national reference center","volume":"54","author":"Ziesing","year":"2016","journal-title":"Med Mycol"},{"key":"10.1016\/j.jcf.2018.01.008_bb0030","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.biocel.2014.03.001","article-title":"Fungi in the cystic fibrosis lung: bystanders or pathogens?","volume":"52","author":"Chotirmall","year":"2014","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"10.1016\/j.jcf.2018.01.008_bb0035","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11046-017-0173-1","article-title":"Toward the standardization of mycological examination of sputum samples in cystic fibrosis: results from a French multicenter prospective study","volume":"183","author":"Coron","year":"2018","journal-title":"Mycopathologia"},{"issue":"1","key":"10.1016\/j.jcf.2018.01.008_bb0040","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11046-017-0184-y","article-title":"Fungal pathogens in CF airways: leave or treat?","volume":"183","author":"Singh","year":"2018","journal-title":"Mycopathologia"},{"issue":"3","key":"10.1016\/j.jcf.2018.01.008_bb0045","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1164\/rccm.201106-1027OC","article-title":"Cystic fibrosis transmembrane conductance regulator regulates epithelial cell response to Aspergillus and resultant pulmonary inflammation","volume":"185","author":"Chaudhary","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.jcf.2018.01.008_bb0050","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/cid\/cir399","article-title":"Inflammatory responses to individual microorganisms in the lungs of children with cystic fibrosis","volume":"53","author":"Gangell","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.jcf.2018.01.008_bb0055","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1164\/rccm.200603-423OC","article-title":"Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis","volume":"174","author":"Kraemer","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jcf.2018.01.008_bb0060","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ppul.1950080106","article-title":"Correlation of IgE antibody titer to Aspergillus fumigatus with decreased lung function in cystic fibrosis","volume":"8","author":"Nicolai","year":"1990","journal-title":"Pediatr Pulmonol"},{"issue":"6","key":"10.1016\/j.jcf.2018.01.008_bb0065","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1164\/ajrccm.155.6.9196093","article-title":"Sensitization to Aspergillus fumigatus and lung function in children with cystic fibrosis","volume":"155","author":"Wojnarowski","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.jcf.2018.01.008_bb0070","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s10096-007-0376-3","article-title":"Aspergillus infection in lung transplant patients: incidence and prognosis","volume":"26","author":"Iversen","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"12","key":"10.1016\/j.jcf.2018.01.008_bb0075","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1128\/JCM.01928-12","article-title":"Disseminated Trichosporon mycotoxinivorans, Aspergillus fumigatus, and Scedosporium apiospermum coinfection after lung and liver transplantation in a cystic fibrosis patient","volume":"50","author":"Hirschi","year":"2012","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.jcf.2018.01.008_bb0080","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1055\/s-0035-1546750","article-title":"Fungi in cystic fibrosis and non-cystic fibrosis bronchiectasis","volume":"36","author":"Moss","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jcf.2018.01.008_bb0085","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11046-017-0182-0","article-title":"Progress in definition, prevention and treatment of fungal infections in cystic fibrosis","volume":"183","author":"Schwarz","year":"2018","journal-title":"Mycopathologia"},{"issue":"3","key":"10.1016\/j.jcf.2018.01.008_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2013.04.007","article-title":"Novel immunologic classification of aspergillosis in adult cystic fibrosis","volume":"132","author":"Baxter","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.jcf.2018.01.008_bb0095","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jaci.2015.07.045","article-title":"The basophil surface marker CD203c identifies Aspergillus species sensitization in patients with cystic fibrosis","volume":"137","author":"Mirkovi\u0107","year":"2016","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.jcf.2018.01.008_bb0100","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1378\/chest.09-1103","article-title":"The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis","volume":"137","author":"Amin","year":"2010","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.jcf.2018.01.008_bb0105","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1378\/chest.130.1.222","article-title":"Aspergillus bronchitis in cystic fibrosis","volume":"130","author":"Shoseyov","year":"2006","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.jcf.2018.01.008_bb0110","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/j.ejrad.2011.01.114","article-title":"Radiological abnormalities associated with Aspergillus colonization in a cystic fibrosis population","volume":"81","author":"McMahon","year":"2012","journal-title":"Eur J Radiol"},{"issue":"1","key":"10.1016\/j.jcf.2018.01.008_bb0115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1569-1993(02)00141-8","article-title":"Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients","volume":"2","author":"Lee","year":"2003","journal-title":"J Cyst Fibros"},{"issue":"11","key":"10.1016\/j.jcf.2018.01.008_bb0120","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0954-6111(99)90270-6","article-title":"Prophylactic antibiotic therapy is associated with an increased prevalence of Aspergillus colonization in adult cystic fibrosis patients","volume":"93","author":"Bargon","year":"1999","journal-title":"Respir Med"},{"issue":"8","key":"10.1016\/j.jcf.2018.01.008_bb0125","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/ppul.21240","article-title":"Risk factors for Aspergillus colonization and allergic bronchopulmonary aspergillosis in children with cystic fibrosis","volume":"45","author":"Jubin","year":"2010","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"10.1016\/j.jcf.2018.01.008_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036077","article-title":"Treatment of Aspergillus fumigatus in patients with cystic fibrosis: a randomized, placebo-controlled pilot study","volume":"7","author":"Aaron","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.jcf.2018.01.008_bb0135","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1007\/s10096-015-2474-y","article-title":"Aspergillus fumigatus chronic colonization and lung function decline in cystic fibrosis may have a two-way relationship","volume":"34","author":"Noni","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.jcf.2018.01.008_bb0140","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/13693780802609604","article-title":"Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis\u2014a review","volume":"47","author":"Pihet","year":"2009","journal-title":"Med Mycol"},{"key":"10.1016\/j.jcf.2018.01.008_bb0145","first-page":"211","article-title":"Fungal colonization and immune response to fungi in cystic fibrosis","volume":"5","author":"Cimon","year":"1995","journal-title":"J Mycol Med"},{"issue":"5","key":"10.1016\/j.jcf.2018.01.008_bb0150","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1086\/314727","article-title":"Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis","volume":"179","author":"Burns","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jcf.2018.01.008_bb0155","doi-asserted-by":"crossref","first-page":"10241","DOI":"10.1038\/srep10241","article-title":"Lung microbiota across age and disease stage in cystic fibrosis","volume":"5","author":"Coburn","year":"2015","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.jcf.2018.01.008_bb0160","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1513\/AnnalsATS.201511-781OC","article-title":"The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease Registry","volume":"13","author":"Knapp","year":"2016","journal-title":"Ann Am Thorac Soc"},{"issue":"4","key":"10.1016\/j.jcf.2018.01.008_bb0165","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2307\/2531734","article-title":"Models for longitudinal data: a generalized estimating equation approach","volume":"44","author":"Zeger","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.jcf.2018.01.008_bb0170","series-title":"Cystic Fibrosis Foundation Patient Registry 2013 annual data report","first-page":"2014","author":"Foundation CF","year":"2014"},{"issue":"8","key":"10.1016\/j.jcf.2018.01.008_bb0175","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/mmy\/myw035","article-title":"Fungal epidemiology and diversity in cystic fibrosis patients over a 5-year period in a national reference center","volume":"54","author":"Ziesing","year":"2016","journal-title":"Med Mycol"},{"issue":"1","key":"10.1016\/j.jcf.2018.01.008_bb0180","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/(SICI)1099-0496(199601)21:1<6::AID-PPUL1>3.0.CO;2-R","article-title":"Clinical significance of the recovery of Aspergillus species from the respiratory secretions of cystic fibrosis patients","volume":"21","author":"Milla","year":"1996","journal-title":"Pediatr Pulmonol"},{"issue":"9","key":"10.1016\/j.jcf.2018.01.008_bb0185","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00431-005-1701-4","article-title":"Risk factors for allergic bronchopulmonary aspergillosis and sensitisation to Aspergillus fumigatus in patients with cystic fibrosis","volume":"164","author":"Ritz","year":"2005","journal-title":"Eur J Pediatr"},{"issue":"7","key":"10.1016\/j.jcf.2018.01.008_bb0190","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/mmy\/myu038","article-title":"Inhaled corticosteroids and Aspergillus fumigatus isolation in cystic fibrosis","volume":"52","author":"Noni","year":"2014","journal-title":"Med Mycol"},{"issue":"9","key":"10.1016\/j.jcf.2018.01.008_bb0195","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/j.1469-0691.2010.03429.x","article-title":"Aspergillus fumigatus colonization in cystic fibrosis: implications for lung function?","volume":"17","author":"de Vrankrijker","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"10.1016\/j.jcf.2018.01.008_bb0200","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1164\/rccm.201407-1277OC","article-title":"Early respiratory infection is associated with reduced spirometry in children with cystic fibrosis","volume":"190","author":"Ramsey","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.jcf.2018.01.008_bb0205","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJM199901073400104","article-title":"Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic fibrosis inhaled tobramycin study group","volume":"340","author":"Ramsey","year":"1999","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jcf.2018.01.008_bb0210","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1378\/chest.08-1421","article-title":"Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosis","volume":"135","author":"Retsch-Bogart","year":"2009","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.jcf.2018.01.008_bb0215","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/jcp.52.5.385","article-title":"Pseudomonas aeruginosa pyocyanin and 1-hydroxyphenazine inhibit fungal growth","volume":"52","author":"Kerr","year":"1999","journal-title":"J Clin Pathol"},{"issue":"8","key":"10.1016\/j.jcf.2018.01.008_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134692","article-title":"Inhibition of Aspergillus fumigatus and its biofilm by Pseudomonas aeruginosa is dependent on the source, phenotype and growth conditions of the bacterium","volume":"10","author":"Ferreira","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jcf.2018.01.008_bb0225","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12890-017-0416-4","article-title":"Co-colonisation with Aspergillus fumigatus and Pseudomonas aeruginosa is associated with poorer health in cystic fibrosis patients: an Irish registry analysis","volume":"17","author":"Reece","year":"2017","journal-title":"BMC Pulm Med"},{"issue":"12","key":"10.1016\/j.jcf.2018.01.008_bb0230","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1164\/rccm.200402-200OC","article-title":"Azithromycin blocks neutrophil recruitment in Pseudomonas endobronchial infection","volume":"170","author":"Tsai","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.jcf.2018.01.008_bb0235","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/thoraxjnl-2012-202412","article-title":"Intravenous antibiotics reduce the presence of Aspergillus in adult cystic fibrosis sputum","volume":"68","author":"Baxter","year":"2013","journal-title":"Thorax"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199318300110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199318300110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:39:38Z","timestamp":1761601178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199318300110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1569199318300110"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2018.01.008","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for persistent Aspergillus respiratory isolation in cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2018.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}